Insights

On September 9, 2026, the European Commission proposed a new Public Procurement Act that would fundamentally change the way that public procurement is regulated across the EU. In this alert we look at what changes have been proposed, and discuss how those changes would affect companies – whether EU-based or not — that wish to participate in European public procurement.  

In this sixth alert in our weekly series on the EU Pharma Package, we focus on the proposals of the European Commission, European Parliament and Council of the EU for another topic with a highly debated scope and with diverging interpretations across EU Member States: the “Bolar” exemption.

In our first alert in this weekly series on the EU Pharma Package, we provided some important background and general information about the status of the Pharma Package and how the trilogues work. In the second alert, we discussed the proposed changes to regulatory data protection. Our third alert delved into the different proposals of the European Commission, Parliament, and the Council regarding the transferable exclusivity voucher (TEV) for priority antimicrobials.